< BACK TO NEWS
positiveSYS.SOURCE: Alzheimer's Association2026-08-15T15:58:53Z

Semaglutide Associated with 26% Reduction in 5-Year Dementia Risk Prediction

A study published in the Alzheimer's Association journal found that semaglutide is associated with a 26% lower 5-year predicted dementia risk. The research suggests potential therapeutic implications for neurodegenerative disease prevention.

Comments

Read original article

*** END OF TRANSMISSION ***